Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-Mefloquine for uncomplicated Plasmodium falciparum malaria in Cambodia
ACTRN12618001301257Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and mefloquine in Malaria, sponsored by Ministry of Health. Primary endpoint: PCR-confirmed treatment success. Started Oct 2017; status: completed.
02
Drugs
artesunatemefloquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12618001301257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001301257.